We are live on
!
Find out more
MCM
Marathon Capital Management Portfolio holdings
AUM
$494M
1-Year Est. Return
42.6%
This Fund
S&P 500
This Quarter
Est. Return
+6.01%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$398M
AUM Growth
+$456K
(+0.11%)
Cap. Flow
-$15M
Cap. Flow
% of AUM
-3.78%
Top 10 Holdings %
Top 10 Hldgs %
43.03%
Holding
164
New
6
Increased
27
Reduced
86
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$6.19M |
| 2 |
Diamondback Energy
FANG
|
+$5.29M |
| 3 |
Allison Transmission
ALSN
|
+$1.27M |
| 4 |
Copa Holdings
CPA
|
+$577K |
| 5 |
Nabors Industries
NBR
|
+$485K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Transocean
RIG
|
+$8.76M |
| 2 |
T. Rowe Price
TROW
|
+$3.93M |
| 3 |
Bank of Montreal
BMO
|
+$2.53M |
| 4 |
HDSN
Hudson Technologies
HDSN
|
+$1.85M |
| 5 |
Blue Bird Corp
BLBD
|
+$1.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.13% |
| 2 | Technology | 17.5% |
| 3 | Industrials | 12.92% |
| 4 | Healthcare | 10.38% |
| 5 | Energy | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Stereotaxis
STXS
$141M
| $21.4K | 0.01% |
12,250
| – | – |
|
152
Kopin
KOPN
$791M
| $20.3K | 0.01% |
10,000
| – | – |
|
153
Aqua Metals
AQMS
$10.2M
| $11.4K | ﹤0.01% |
75
| – | – |
|
154
Aegon
AEG
$14.1B
| – | – |
-13,326
| Closed | -$64K |
|
155
BP
BP
$107B
| – | – |
-7,531
| Closed | -$292K |
|
156
Cerus
CERS
$474M
| – | – |
-26,000
| Closed | -$42.1K |
|
157
Conduent
CNDT
$264M
| – | – |
-82,075
| Closed | -$286K |
|
158
Cisco
CSCO
$479B
| – | – |
-4,659
| Closed | -$250K |
|
159
CVS Health
CVS
$122B
| – | – |
-2,913
| Closed | -$203K |
|
160
Quantum Corp
QMCO
$474M
| – | – |
-2,500
| Closed | -$30.5K |
|
161
Comscore
SCOR
$109M
| – | – |
-625
| Closed | -$7.63K |
|
|
DM
162
DELISTED
Desktop Metal, Inc.
DM
| – | – |
-3,500
| Closed | -$51.1K |
|
|
IBTD
163
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
| – | – |
-33,000
| Closed | -$819K |
|
|
AVID
164
DELISTED
Avid Technology Inc
AVID
| – | – |
-15,550
| Closed | -$418K |
|
Similar funds
LI
SAS
BFIC
FSA
TAM
TAA
NYLIC
MA
Marathon Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Marathon Capital Management held 164 positions worth $398M, up 0.11% from $397M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Marathon Capital Management withdrew a net $15M in Q4 2023, closing 11 positions and reducing 86 holdings. Its most notable exit was iShares iBonds Dec 2023 Term Treasury ETF, an estimated $819K position sold in full.
By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Marathon Capital Management opened a new position in AstraZeneca worth $6.41M.
- Marathon Capital Management's largest Q4 2023 buy was AstraZeneca: 47,595 shares worth $6.41M.
- Marathon Capital Management added most to Diamondback Energy in Q4 2023, an estimated $5.29M increase.
- Marathon Capital Management's biggest Q4 2023 reduction was Transocean, cutting an estimated $8.76M.
- Marathon Capital Management fully exited iShares iBonds Dec 2023 Term Treasury ETF in Q4 2023, selling an estimated $819K.
- Marathon Capital Management's ten largest holdings make up 43% of its $398M portfolio in Q4 2023.
- Marathon Capital Management opened 6 new positions and closed 11 in Q4 2023.
- Marathon Capital Management's portfolio value rose 0.11% quarter-over-quarter to $398M.
Based on Marathon Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.